Overview
- 12 inspections across 12 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-06-24.
At a glance
Inspections
12
Sites
12
Observations
8
Career since
Aug 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Watson Pharma Private Limited | 24 Jun 2016 | Human Drugs | |
| AstraZeneca Dunkerque Production | 20 Nov 2015 | Human Drugs | On file |
| Altergon Italia SRL | 13 Nov 2015 | Human Drugs | |
| Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. SPA | 6 Nov 2015 | Human Drugs | |
| Alembic Pharmaceuticals Limited | 23 Apr 2015 | Human Drugs | On file |
Sites inspected
Watson Pharma Private LimitedVerna, India1 insp.
AstraZeneca Dunkerque ProductionDordogne, France1 insp.
Altergon Italia SRLMorra De Sanctis, Italy1 insp.
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. SPAAprilia, Italy1 insp.
Alembic Pharmaceuticals LimitedVadodara, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael E Maselli2 shared
Tina M Pawlowski2 shared
Full investigator report
Get the verbatim findings behind James L Dunnie's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site